RxDoctor Payments Data

Thomas Scott

Allergy & Immunology · Bessemer, ALNPI 1043247430

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $53,199 of the $61,245 with a category attached, or 86.9%. 26 manufacturers reported payments, led by Amgen at 52.8% of the total. Reporting peaked in 2019 at $31,875 and has fallen 99.5% since, to $160 in 2025.

$61,245in general payments, 2019–2025

Across 247 payments — averaging $247.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$32K
  • GSK$24K
  • AstraZeneca$2K
  • Pfizer$371
  • Bristol Myers Squibb$273
  • Optinose US, Inc.$254
  • plus $2K from 20 others
$4,000in research payments, 2019–2025

Across 1 payment — averaging $4000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$4K

What the payments were for

  • Consulting fees$1,1632%
  • Speaking & faculty fees$53,19987%
  • Travel & lodging$6941%
  • Food & beverage$6,17810%
  • Education$120%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,245 in reported general payments places this provider in the 85th percentile of 30 allergy & immunology providers in Alabama.

See all allergy & immunology providers in Alabama

Other allergy & immunology in Bessemer

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →